Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Jun 6, 2014

NEW YORK (GenomeWeb) – The New York Genome Center has named Harold Swerdlow its VP of Technology Innovation.

In the role, he will be responsible for developing technologies to be used in genomics research and in clinical applications, including microfluidic tools for reducing the cost of single-cell and other DNA preparation methods for next-generation sequencing.

Swerdlow formerly was head of R&D at the Wellcome Trust Sanger Institute, he formerly was chief technology officer at Dolomite, and he was senior director of research at Solexa.

Affymetrix's shareholders this week voted to re-elect the members of the firm's board of directors. The shareholders re-elected Stephen Fodor; Frank Witney; Nelson Chan; Gary Guthart; Jami Nachtsheim (as lead director); Robert Trice; and Robert Wayman.

Charles Cantor and Bhubaneswar (Bud) Mishra have joined InSilico Medicine's scientific advisory board.

Cantor, who will serve as the SAB's chair, co-founded Sequenom and is a professor emeritus at Boston University, distinguished adjunct professor at the University of California, Irvine, and an adjunct professor at the Moscow Institute of Physics and Technology and also at Scripps Research Institute. He formerly was director of the Center for Advanced Biotechnology at Boston University, chairman of Genetics and Development at Columbia University College of Physicians and Surgeons, and a professor of molecular biology at the University of California, Berkeley.

Mishra is a professor of computer science and mathematics at New York University's Courant Institute of Mathematical Sciences, professor of human genetics at Mt. Sinai School of Medicine, and a professor of cell biology at NYU School of Medicine. He founded the NYU/Courant Bioinformatics Group, a multi-disciplinary group working on research at the interface of computer science, applied mathematics, and biology.

Exosome Diagnostics said this week that it has appointed Vincent O'Neill its chief medical officer.

O'Neill most recently served as global head of personalized medicine and companion diagnostics at Sanofi. Prior to this, he managed the clinical development programs of several oncology therapeutic candidates at Genentech and GlaxoSmithKline.

Atossa Genetics has hired John Sawyer to be senior VP of global regulatory affairs and quality assurance, replacing Ben Chen. Sawyer has been an advisor for Atossa for the past 15 months, and he now will be responsible for executing the firm's regulatory strategy in the US and in international markets.

Sawyer previously owned his own consulting firm, Realistic Quality Solutions. He also previously was VP of quality assurance and regulatory affairs for Welch-Allyn, and he held other leadership posts at Fujifilm Medical Systems and GE OEC Medical Systems.

Caris Life Sciences has promoted Sandeep Reddy to chief medical officer. He was previously senior medical director at Caris. In his new role, he will lead the company's research efforts through the Caris Research Institute and guide strategy for the deployment of Caris' precision medicine tools in the clinical setting.

BioData, which offers a web-based research and lab management service, said this week it has appointed Michael Tomasic to serve on its board of directors.

Tomasic was president and CEO of CambridgeSoft for 20 years, and he continued to lead the company after it was acquired by PerkinElmer in 2011, and he was chairman of LabTech Corporation for over 20 years. He currently is president of Management Technology and provides consulting services for the biotech, software, and computing industries.

Human Metabolome Technologies said that Alexander Buko has been named VP of HMT America. He most recently served as senior director of translational medicine at Biogen Idec. Buko will lead project management and develop HMT's biomarker based platforms.

Promoted? Changing jobs? GenomeWeb wants to know. [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.